Navigation Links
Stimulation of the semicircular canals can artificially control human walking and balance

By applying electrical currents across the heads of people while they walk, researchers have improved our understanding of how our vestibular system helps us maintain upright posture; at the same time, the researchers found that the stimulus could be applied in a way that allowed a person who was walking straight ahead to be steered by "remote control" without her balance being affected. The findings are reported by Richard Fitzpatrick and Jane E. Butler of the Prince of Wales Medical Research Institute and the University of New South Wales, Australia, and Brian L. Day of University College London in the August 8th issue of Current Biology, published by Cell Press.

To investigate how the body's ability to sense head movements can contribute to balance control and guidance control--two critical aspects of bipedal locomotion--the researchers stimulated nerves that normally communicate signals from the so-called semicircular canals, structures that are part of the vestibular system that assists in orientation and balance. The researchers found that artificial stimulation of semiciruclar canal nerves afforded "remote control" that was accurate enough to keep subjects on pathways and avoiding obstacles while walking blindfolded through botanical gardens. The researchers also found that with a subject's head in another position, exactly the same stimulus could be used to disturb upright balance, causing the subject to lean in one direction or the other, but without having any effect on steering his walking.

Known as bipedalism, our habitual upright posture is unique in the animal kingdom and has arisen through specific complementary adaptations of the body and brain. It has been believed that the key to human balance has come from a precise sense of--and ability to align the body to--the direction of gravity.

However, the semicircular canals that the researchers stimulated to control walking and balance detect rotational movements of the head, no
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Bacteria could make new library of cancer drugs that are too complex to create artificially
2. Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds
3. Ancient olfaction protein is shared by many bugs, offering new pest control target
4. Gene variations explain drug dose required to control seizures
5. U-M scientists find genes that control growth of common skin cancer
6. Scientists discuss improved biopesticides for locust control in West Africa
7. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy
8. To control germs, scientists deploy tiny agents provocateurs
9. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
10. Master gene controls healing of skin in fruit flies and mammals
11. Remote control flies? Fly behavior controlled by laser light

Post Your Comments:
(Date:11/9/2009)...O, Calif., Nov. 9 Genencor, a divi... Energy Award" from the American Institute of Chem...amily of enzymes for cellulosic ethanol. Yesterday...e, presented the award to Landon Steele, who is Ma...#174; Product Manager, and Aaron Kelley, who is Se...
(Date:11/9/2009)... culprit responsible for the rapid, mysterious dea...s been found by collaborating scientists at Rutger...itution (WHOI). This same chemical may hold unexp...covered a previously unknown lipid, or fatty compo...g Emiliania huxleyi , a phytoplankton that plays ...
(Date:11/9/2009)..., NOVEMBER 9, 2009 A nutritionist whose research...to the federal Women, Infants and Children (WIC) f...Higgins Award for outstanding achievement in the f...son, Ph.D., MNS, , a professor in the Department o...alifornia, Los Angeles School of Public Health, wi...
Breaking Biology News(10 mins):Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 1DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 2DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 3Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 1Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 2Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 3
...he primary targets of HIV-1 infection in the human... study published in the February 2007 issue of the...ndings are likely to guide development of new stra...he majority of HIV-1 infected individuals worldwid...xual contact," explain study authors Dr. Florian H...
...n his Jan. 23 State of the Union address, Presiden...on,s dependency on foreign oil by requiring the pr... and alternative fuels by 2017, roughly five times... gallons by 2012. , Among the most promising alter.... Currently, the main biofuel used in the United S...
...n his Jan. 23 State of the Union address, Presiden...on,s dependency on foreign oil by requiring the pr... and alternative fuels by 2017, roughly five times... gallons by 2012. , Among the most promising alter.... Currently, the main biofuel used in the United S...
Other Biology News:Researchers discover new details about HIV-1 entry and infection 2Custom-made cancer cell attacks 2Custom-made cancer cell attacks 3Cellulosic ethanol: Fuel of the future? 2Cellulosic ethanol: Fuel of the future? 3
(Date:11/6/2009)...wire-FirstCall/ - Microbix Biosystems Inc. (the "C...Form 52-109F1 Certification of Annual Filings of W...es Long, the Chief Financial Officer (the "Officer...tion with the annual audited financial statements ...ompany initially filed the annual financial statem...
(Date:11/6/2009)... Helix BioPharma Corp. (...ced that John Docherty, president and chief operat...s 6th annual Investor Summit on November 10, 2009 ... Mr. Docherty will provide an overview of the Comp... and Topical Interferon Alpha-2b. The slide show ...
(Date:11/6/2009)...vember 6 EUCODIS Bioscience, a com...arketing enzymes for the,chemical industry announc...ment with Bio Sidus, the leading biopharmaceutical...t gives EUCODIS Bioscience exclusive access - for ...proprietary collection of,psychrophilic bacteria s...
(Date:11/6/2009)...Nov. 6 Calbiotech, Inc. announced ...novative Research (SBIR) Phase I contract by the U...der terms of the agreement, Calbiotech will develo...is of Dengue virus. ,, Dengue virus is a mos...at to military forces deployed to tropical areas o...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...d., March 16 Micromet, Inc. (Nasdaq: MITI ), a ...etary antibodies for the treatment of cancer, infl...the publication of six abstracts for poster presen... place from April 20-24, 2009, in Denver, Colorado... , , , Lutterbuese, R. et al. (2009). H...
...ch 16 PAREXEL experts will address the benefits o... 110th Annual Meeting of the American Society for ... be held at the Gaylord National Resort in Nationa...ocus of PAREXEL,s presence at the ASCPT meeting wi...nd best practice approaches for identifying and se...
...ng expenses decreased by 33% in 2008; Forecast cut...n 2009 , , CTI expects to complete pixantrone ND...ell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC...ial results for the fourth quarter and year ended ... Met primary endpoint in the Phase III study ...
Other Biology Technology:Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 2Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 3Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 4Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 5PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 2PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 3PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 2Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 3Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 5Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 6Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 7Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 8
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
Goat Anti-DOCK 2 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-PFK-2 car (P-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Ampicillin Monoclonal Antibody, Unconjugated, Clone 164-12-2 from Abcam
Biology Products: